Ratings by Wells Fargo (David Maris)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/16/2022 | Ironwood Pharmaceuticals | IRWD | Maintain | Equal Weight (N/A) |
|
Details | ||
| 3/10/2022 | Emergent BioSolutions | EBS | Maintain | Equal Weight (N/A) |
|
Details | ||
| 10/28/2021 | Teva Pharma | TEVA | Maintain | Equal Weight (N/A) |
|
Details | ||
| 7/29/2021 | Teva Pharma | TEVA | Maintain | Equal Weight (N/A) |
|
Details | ||
| 5/5/2021 | Emergent BioSolutions | EBS | Maintain | Equal Weight (N/A) |
|
Details | ||
| 1/15/2021 | Teva Pharma | TEVA | Maintain | Equal Weight (N/A) |
|
Details | ||
| 1/13/2021 | Emergent BioSolutions | EBS | Maintain | Equal Weight (N/A) |
|
Details | ||
| 1/8/2021 | Jazz Pharmaceuticals | JAZZ | Maintain | Overweight (N/A) |
|
Details | ||
| 1/8/2021 | Emergent BioSolutions | EBS | Downgrade | Equal Weight (Overweight) |
97.97 (8.29) |
-91.54% | Details | |
| 11/3/2020 | Jazz Pharmaceuticals | JAZZ | Maintain | Overweight (N/A) |
|
Details | ||
| 10/28/2020 | Mylan | MYL | Maintain | Equal Weight (N/A) |
|
Details | ||
| 9/30/2020 | Ironwood Pharmaceuticals | IRWD | Downgrade | Equal Weight (Overweight) |
9.53 (3.50) |
-63.27% | Details | |
| 8/13/2020 | Jazz Pharmaceuticals | JAZZ | Maintain | Overweight (N/A) |
|
Details | ||
| 7/2/2020 | Emergent BioSolutions | EBS | Maintain | Overweight (N/A) |
|
Details | ||
| 4/30/2020 | Mylan | MYL | Maintain | Equal Weight (N/A) |
|
Details | ||
| 4/30/2020 | Jazz Pharmaceuticals | JAZZ | Maintain | Overweight (N/A) |
|
Details | ||
| 4/30/2020 | Ironwood Pharmaceuticals | IRWD | Maintain | Overweight (N/A) |
|
Details | ||
| 4/30/2020 | Emergent BioSolutions | EBS | Maintain | Overweight (N/A) |
|
Details | ||
| 2/25/2020 | Emergent BioSolutions | EBS | Maintain | Overweight (N/A) |
|
Details | ||
| 1/22/2020 | Teva Pharma | TEVA | Maintain | Equal Weight (N/A) |
|
Details | ||
| 1/22/2020 | Jazz Pharmaceuticals | JAZZ | Maintain | Overweight (N/A) |
|
Details | ||
| 1/22/2020 | Allergen | AGN | Downgrade | Equal Weight (Overweight) |
192.68 (193.02) |
0.18% | Details | |
| 12/3/2019 | Jazz Pharmaceuticals | JAZZ | Maintain | Overweight (N/A) |
|
Details | ||
| 9/30/2019 | Teva Pharma | TEVA | Maintain | Equal Weight (N/A) |
|
Details | ||
| 9/10/2019 | Bausch Health Companies | BHC | Maintain | Underweight (N/A) |
|
Details | ||
| 9/5/2019 | Mallinckrodt plc | MNK | Maintain | Equal Weight (N/A) |
|
Details | ||
| 9/4/2019 | Emergent BioSolutions | EBS | Upgrade | Overweight (Equal Weight) |
43.80 (8.29) |
-81.07% | Details | |
| 6/28/2019 | Establishment Labs Inc. | ESTA | New Coverage | Overweight (N/A) |
21.00 (70.41) |
235.29% | Details | |
| 6/20/2019 | Bausch Health Companies | BHC | Maintain | Underweight (N/A) |
|
Details | ||
| 6/5/2019 | Sientra | SIEN | Upgrade | Overweight (Equal Weight) |
6.13 (0.17) |
-97.23% | Details | |
| 5/30/2019 | Mylan | MYL | Maintain | Equal Weight (N/A) |
|
Details | ||
| 5/21/2019 | Mallinckrodt plc | MNK | Maintain | Equal Weight (N/A) |
|
Details | ||
| 5/8/2019 | Allergen | AGN | Maintain | Overweight (N/A) |
|
Details | ||
| 5/8/2019 | Mylan | MYL | Downgrade | Equal Weight (Overweight) |
21.53 (15.86) |
-26.34% | Details | |
| 4/3/2019 | Teva Pharma | TEVA | Maintain | Equal Weight (N/A) |
|
Details | ||
| 3/20/2019 | Jazz Pharmaceuticals | JAZZ | Maintain | Overweight (N/A) |
|
Details | ||
| 3/19/2019 | Jazz Pharmaceuticals | JAZZ | Maintain | Overweight (N/A) |
|
Details | ||
| 3/14/2019 | Sientra | SIEN | New Coverage | Equal Weight (N/A) |
11.38 (6.13) |
-46.13% | Details | |
| 3/7/2019 | Allergen | AGN | Maintain | Overweight (N/A) |
|
Details | ||
| 3/7/2019 | Allergen | AGN | Maintain | Overweight (N/A) |
|
Details | ||
| 2/28/2019 | Perrigo Co. | PRGO | Maintain | Equal Weight (N/A) |
|
Details | ||
| 2/15/2019 | Revance Therapeutic | RVNC | New Coverage | Equal Weight (N/A) |
17.78 (15.42) |
-13.27% | Details | |
| 2/14/2019 | Teva Pharma | TEVA | Maintain | Equal Weight (N/A) |
|
Details | ||
| 12/21/2018 | Jazz Pharmaceuticals | JAZZ | Maintain | Overweight (N/A) |
|
Details | ||
| 12/21/2018 | Perrigo Co. | PRGO | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 12/19/2018 | Allergen | AGN | Maintain | Overweight (N/A) |
|
Details | ||
| 12/12/2018 | Bausch Health Companies | BHC | Maintain | Underweight (N/A) |
|
Details | ||
| 12/12/2018 | Emergent BioSolutions | EBS | Maintain | Equal Weight (N/A) |
|
Details | ||
| 11/19/2018 | Bausch Health Companies | BHC | Maintain | Underweight (N/A) |
|
Details | ||
| 11/19/2018 | Mallinckrodt plc | MNK | Maintain | Equal Weight (N/A) |
|
Details | ||
| 11/14/2018 | Neos Therapeutics | NEOS | Maintain | Overweight (N/A) |
|
Details | ||
| 11/6/2018 | Mallinckrodt plc | MNK | Maintain | Equal Weight (N/A) |
|
Details | ||
| 11/6/2018 | Mylan | MYL | Upgrade | Overweight (Equal Weight) |
31.37 (21.53) |
-31.37% | Details | |
| 10/31/2018 | Ironwood Pharmaceuticals | IRWD | Maintain | Overweight (N/A) |
|
Details | ||
| 10/17/2018 | Teva Pharma | TEVA | Maintain | Equal Weight (N/A) |
|
Details | ||
| 10/8/2018 | Mallinckrodt plc | MNK | Maintain | Equal Weight (N/A) |
|
Details | ||
| 10/4/2018 | Bausch Health Companies | BHC | Maintain | Underweight (N/A) |
|
Details | ||
| 9/12/2018 | Bausch Health Companies | BHC | Maintain | Underweight (N/A) |
|
Details | ||
| 8/21/2018 | Perrigo Co. | PRGO | Maintain | Equal Weight (N/A) |
|
Details | ||
| 8/15/2018 | Mylan | MYL | Maintain | Equal Weight (N/A) |
|
Details | ||
| 8/15/2018 | Jazz Pharmaceuticals | JAZZ | Maintain | Overweight (N/A) |
|
Details |
